However many drug resistance problems over the past decades have also been the result of invasive fungal diseases largely underrecognized by scientists, governments, clinicians and pharmaceutical ...
The drug is being developed to treat invasive fungal infections including aspergillosis - a rare infection that is resistant to antifungal medication. The U.S. Food and Drug Administration ...
The latest round would help the UK-based company complete a global late-stage study of its lead drug, olorofim. The drug is being developed to treat invasive fungal infections including aspergillosis ...